Virtual Reality (VR) Self-Hypnosis Software

Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Apr 30, 2024

Keywords

ClinConnect Summary

This clinical trial is testing a new virtual reality (VR) self-hypnosis program designed to help relieve chronic pain in adults living with HIV. The study will use a VR headset (OculusGo™) to see if this software is safe, easy to use, and effective in reducing pain. Researchers are particularly focused on patients who have been experiencing pain related to HIV for at least three months and are on a stable treatment plan.

To participate, you must be at least 18 years old, have a confirmed diagnosis of HIV, and have had chronic pain for over 90 days. You also need access to the internet and be able to understand and speak English. Participants can expect to use the VR software in a structured way as part of the study, while also helping researchers learn more about how this technology can help manage pain. It's important to note that there are some health conditions that may prevent you from participating, such as certain neurological issues or if you are currently pregnant. If you think you might qualify and are interested, please stay tuned as the trial is not yet recruiting participants.

Gender

ALL

Eligibility criteria

• • Patient Eligibility
• Inclusion Criteria:
• • Adults age ≥18
• • Confirmed diagnosis of HIV, currently on a stable antiretroviral regimen ≥ 90 days.
• • Documentation of chronic pain associated with HIV for≥90 days
• • Stable pain management regimen ≥90 days, or no pain treatments ≥90 days
• • Average pain intensity of 3 or greater on the NRS of the mean daily scores reported between Visit 1 and Visit 2
• • Access to the internet via smartphone, computer, or tablet 7. Fluent in English
• • Capable of giving informed consent and willingness to comply with study procedures.
• Exclusion Criteria:
• • A co-occurring medical or psychiatric condition which would make participation in the study or complicate measurement of changes associated with the intervention.
• • Concurrent participation in another investigational protocol for pain treatment
• • A psychiatric disorder, medical condition, or other life circumstance, which in the opinion of the PI, would contraindicate attendance at sessions, or make it unlikely that the participant could successfully complete the study procedures.
• • Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological conditions contraindicating the use of virtual reality devices.
• • A medical condition predisposing prospective participant to nausea or dizziness 6. Lack of stereoscopic vision or severe hearing impairment
• • Injury to eyes, face, or neck that impedes using the VR device
• • If participant has access to personal VR gear for gaming or other purposes at home, participant fails to agree not to use these personal VR gear during the course of the protocol.
• • Currently pregnant or planning to become pregnant during the study period